ERBB2 and neoplasm: In HER2+ subtype, univariate analysis showed that the SD pattern and change in tumor size were associated with pCR; multivariate analysis showed that the change in tumor size was the only independent factor to predict pCR (OR = 1.75; 95% CI 1.20–2.56; p = 0.004).